H. Celik And E. ARINÇ, "Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4," XENOBIOTICA , vol.43, no.3, pp.263-275, 2013
Celik, H. And ARINÇ, E. 2013. Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4. XENOBIOTICA , vol.43, no.3 , 263-275.
Celik, H., & ARINÇ, E., (2013). Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4. XENOBIOTICA , vol.43, no.3, 263-275.
Celik, Haydar, And Emel ARINÇ. "Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4," XENOBIOTICA , vol.43, no.3, 263-275, 2013
Celik, Haydar And ARINÇ, Emel. "Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4." XENOBIOTICA , vol.43, no.3, pp.263-275, 2013
Celik, H. And ARINÇ, E. (2013) . "Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4." XENOBIOTICA , vol.43, no.3, pp.263-275.
@article{article, author={Haydar ÇELİK And author={Emel ARINÇ}, title={Evaluation of bioreductive activation of anticancer drugs idarubicin and mitomycin C by NADH-cytochrome b5 reductase and cytochrome P450 2B4}, journal={XENOBIOTICA}, year=2013, pages={263-275} }